The United States Food and Drug Administration recently approved Oliceridine, also known as “Olinvyk,” an opioid primarily concerned in treating severe acute pain, by biopharmaceutical company, Trevena, last August 7, 2020. After years of getting the FDA to approve the drug, Trevena, Inc., finally received approval this year. Trevena initially submitted the drug for review...
Tag: <span>researchers</span>
CAN BOOSTING THE IMMUNE SYSTEM TREAT COVID-19?
Boosting the immune system could offer a potential treatment strategy for COVID-19, according to a new study. As the COVID-19 pandemic continues to claim lives around the world, much research has focused on the immune system’s role in patients who become seriously ill. A popular theory has it that the immune system gets so revved...
Nanocatalysts that remotely control chemical reactions inside living cells
POHANG UNIVERSITY OF SCIENCE & TECHNOLOGY (POSTECH) DIAGRAM OF REMOTELY CONTROLLED CATALYSIS IN LIVING CELLS USING MAG-NER AND THE ELECTRON MICROSCOPE IMAGE OF MAG-NERview more CREDIT: IN SU LEE (POSTECH) The enzymes responsible for catalytic reactions in our body’s biological reactions are difficult to use for diagnosis or treatment as they react only to certain...
New approach to treating osteoarthritis advances
by NYU Langone Health The study results revolve around the long-established idea that machines within animal and human cells turn the sugars, fats, and proteins we eat into energy used by the body’s millions of cells. The molecule most used to store that energy is called adenosine triphosphate, or ATP. Along with this central role...
COVID-19 may have a longer incubation period, suggests probability analysis of Wuhan cases
Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE By applying the renewal theory in probability to reduce recall bias in initial case reports, scientists have come up with a new estimate for the incubation period of COVID-19....
Key gene identified for improving multiple sclerosis treatment
by Karolinska Institutet The disease multiple sclerosis (MS) attacks the central nervous system and, with time, can give rise to muscle tremors and loss of balance. Researchers at Karolinska Institutet have now identified a gene, Gsta4, that protects a certain kind of cell in the brain from being destroyed. It is hoped that the results...
Experimental treatment confers benefits for the alleviation of nonalcoholic hepatic steatosis
by Liu Jia, Chinese Academy of Sciences Prof. Liu Hongwei’s group and Prof. Liu Shuangjiang’s group from the Institute of Microbiology of the Chinese Academy of Sciences has reported the anti-NAFLD effects of a Ganoderma meroterpene derivative that increased the abundance of Bacteroides spp. to activate Bacteroides-folate-liver pathway and further alleviate nonalcoholic fatty liver disease...
Creating a blood test for the detection of Alzheimer’s disease
Interview conducted by Emily Henderson, B.Sc. News-Medical spoke to Dr. Randall Bateman and Dr. Nicolas Barthélemy from Washington University about their research on Alzheimer’s disease, and their new technique that can detect Alzheimer’s from a blood test. Why did you choose to research Alzheimer’s and its detection? Alzheimer’s disease offers incredible potential for impact. As...
U of T researchers discover how to get more cancer-fighting nanoparticles to where they’re needed
Researchers in the University of Toronto’s Faculty of Applied Science & Engineering have discovered a dose threshold that greatly increases the delivery of cancer-fighting drugs into a tumour. The findings, published recently in the journal Nature Materials, provide a potentially universal method for gauging nanoparticle dosage and could help advance a new generation of cancer...
Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19
VASCULAR LEAKAGE, INFLAMMATION-PROVOKING, AND THROMBOTIC EVENTS IN CORONAVIRUS DISEASE 2019 view more CREDIT: NOVATEUR VENTURES A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled ‘A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes’ was published in Frontiers in Pharmacology, a...